Yhb Investment Advisors, Inc. Pfizer Inc Transaction History

Yhb Investment Advisors, Inc.

$1.19 Billion
Q3 2024

A detailed history of Yhb Investment Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Yhb Investment Advisors, Inc. holds 63,137 shares of PFE stock, worth $1.62 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

63,137

Previous 69,243 8.82%

Holding current value

$1.62 Million

Previous $1.94 Million 5.68%

% of portfolio

0.15%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $169,136 - $191,667	-6,106 Reduced 8.82%	63,137 $1.83 Million
Q2 2024 Aug 01, 2024	BUY	$25.26 - $29.6 $117,433 - $137,610	4,649 Added 7.2%	69,243 $1.94 Million
Q1 2024 Aug 14, 2024	SELL	$25.89 - $29.73 $120,362 - $138,214	-4,649 Reduced 6.71%	64,594 $1.79 Million
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $112,440 - $129,117	-4,343 Reduced 6.3%	64,594 $1.79 Million
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $172,771 - $224,411	-6,612 Reduced 8.75%	68,937 $1.98 Million
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $33,534 - $39,197	-1,045 Reduced 1.36%	75,549 $2.51 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $119,593 - $138,366	-3,311 Reduced 4.14%	76,594 $2.81 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $11,186 - $14,563	284 Added 0.36%	79,905 $3.26 Million
Q4 2022 Jan 12, 2023	SELL	$41.75 - $54.5 $36,239 - $47,306	-868 Reduced 1.08%	79,621 $0
Q3 2022 Nov 03, 2022	BUY	$43.76 - $53.42 $41,046 - $50,107	938 Added 1.18%	80,489 $3.52 Million
Q2 2022 Jul 14, 2022	BUY	$46.53 - $55.17 $3,070 - $3,641	66 Added 0.08%	79,551 $4.17 Million
Q1 2022 Apr 14, 2022	SELL	$45.75 - $56.69 $201,391 - $249,549	-4,402 Reduced 5.25%	79,485 $4.12 Million
Q4 2021 Jan 18, 2022	SELL	$41.32 - $61.25 $77,309 - $114,598	-1,871 Reduced 2.18%	83,887 $4.95 Million
Q3 2021 Oct 28, 2021	SELL	$39.25 - $50.42 $146,520 - $188,217	-3,733 Reduced 4.17%	85,758 $3.69 Million
Q2 2021 Jul 15, 2021	SELL	$35.91 - $40.68 $83,023 - $94,052	-2,312 Reduced 2.52%	89,491 $3.5 Million
Q1 2021 Apr 22, 2021	SELL	$33.49 - $37.77 $160,216 - $180,691	-4,784 Reduced 4.95%	91,803 $3.54 Million
Q4 2020 Jan 21, 2021	BUY	$33.47 - $42.56 $46,991 - $59,754	1,404 Added 1.48%	96,587 $3.56 Million
Q3 2020 Nov 02, 2020	SELL	$31.75 - $37.25 $1.78 Million - $2.09 Million	-56,047 Reduced 37.06%	95,183 $3.49 Million
Q2 2020 Jul 20, 2020	SELL	$30.12 - $36.54 $28,885 - $35,041	-959 Reduced 0.63%	151,230 $4.95 Million
Q1 2020 Apr 16, 2020	SELL	$27.03 - $38.62 $145,070 - $207,273	-5,367 Reduced 3.41%	152,189 $4.97 Million
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $48,030 - $54,508	-1,459 Reduced 0.92%	157,556 $6.17 Million
Q3 2019 Oct 15, 2019	BUY	$32.49 - $42.13 $1.01 Million - $1.31 Million	31,105 Added 24.32%	159,015 $5.71 Million
Q2 2019 Jul 15, 2019	SELL	$36.98 - $41.52 $152,542 - $171,270	-4,125 Reduced 3.12%	127,910 $5.54 Million
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $24,675 - $27,109	-658 Reduced 0.5%	132,035 $5.61 Million
Q4 2018 Jan 11, 2019	BUY	$38.47 - $43.86 $601,786 - $686,101	15,643 Added 13.36%	132,693 $5.79 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $47,327 - $57,405	-1,373 Reduced 1.16%	117,050 $5.16 Million
Q2 2018 Jul 09, 2018	SELL	$32.98 - $35.16 $8,772 - $9,352	-266 Reduced 0.22%	118,423 $4.3 Million
Q1 2018 Apr 16, 2018	SELL	$31.91 - $37.02 $1.06 Million - $1.22 Million	-33,071 Reduced 21.79%	118,689 $4.21 Million
Q4 2017 Jan 16, 2018	BUY	$33.26 - $35.29 $543,867 - $577,062	16,352 Added 12.08%	151,760 $5.5 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $4.2 Million - $4.62 Million	135,408	135,408 $4.83 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.

Account

Yhb Investment Advisors, Inc. Pfizer Inc Transaction History